{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":225217,"items":[{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:44:12Z","timestamp":1649159052213},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53030_02_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:26:59Z","timestamp":1629127619000},"score":21.116365,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53030_02_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53030_02_01"},{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T15:10:08Z","timestamp":1750432208245,"version":"3.41.0"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53040_03_02","type":"standard","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:31:38Z","timestamp":1750429898000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone Capsules"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T14:31:56Z","timestamp":1750429916000},"score":20.749977,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53040_03_02.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53040_03_02"},{"indexed":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T04:30:44Z","timestamp":1692765044156},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53030_03_01","type":"standard","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:11:19Z","timestamp":1692713479000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T14:13:12Z","timestamp":1692713592000},"score":20.29535,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53030_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53030_03_01"},{"indexed":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T06:10:58Z","timestamp":1668492658408},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53070_04_01","type":"standard","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:01:48Z","timestamp":1668438108000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:01:54Z","timestamp":1668438114000},"score":20.214,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53070_04_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53070_04_01"},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T09:09:41Z","timestamp":1648544981073},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53070_03_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone Tablets"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:48:43Z","timestamp":1629125323000},"score":20.145332,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53070_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53070_03_01"},{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:42:41Z","timestamp":1733895761691,"version":"3.30.1"},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53040_03_01","type":"standard","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:35:43Z","timestamp":1733855743000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone Capsules"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:35:49Z","timestamp":1733855749000},"score":20.128998,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53040_03_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53040_03_01"},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:36:36Z","timestamp":1649151396732},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53040_01_01","type":"standard","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T14:18:31Z","timestamp":1629123511000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone Capsules"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T15:10:18Z","timestamp":1629126618000},"score":20.128883,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53040_01_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53040_01_01"},{"indexed":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T06:10:43Z","timestamp":1668492643888},"standards-body":{"name":"United States Pharmacopeial Convention","acronym":"USP"},"reference-count":0,"publisher":"U.S. Pharmacopeial Convention","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.31003\/uspnf_m53040_02_01","type":"standard","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:01:48Z","timestamp":1668438108000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone Capsules"],"prefix":"10.31003","member":"14819","deposited":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T15:02:19Z","timestamp":1668438139000},"score":19.581451,"resource":{"primary":{"URL":"https:\/\/doi.usp.org\/USPNF\/USPNF_M53040_02_01.html"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.31003\/uspnf_m53040_02_01"},{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T10:28:21Z","timestamp":1726050501917},"reference-count":1,"publisher":"Qeios","content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.32388\/vcb2ed","type":"reference-entry","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T15:32:35Z","timestamp":1581089555000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.32388","author":[{"name":"National Cancer Institute","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17262","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"unstructured":"National Cancer Institute. Methyltestosterone. NCI Thesaurus. Code C648.","key":"ref1"}],"container-title":["Definitions"],"language":"en","deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T15:32:35Z","timestamp":1581089555000},"score":18.868038,"resource":{"primary":{"URL":"https:\/\/www.qeios.com\/read\/definition\/69373"}},"issued":{"date-parts":[[2020,2,7]]},"references-count":1,"URL":"https:\/\/doi.org\/10.32388\/vcb2ed","published":{"date-parts":[[2020,2,7]]}},{"indexed":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:28:14Z","timestamp":1664256494908},"reference-count":0,"publisher":"Bloomsbury Academic","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011]]},"DOI":"10.5040\/9781350363595.art-1118","type":"book-chapter","created":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:22:06Z","timestamp":1664202126000},"source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone (m)"],"prefix":"10.5040","member":"2984","container-title":["Drugs Handbook 2012\u20132013"],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T14:44:54Z","timestamp":1664203494000},"score":18.559097,"resource":{"primary":{"URL":"http:\/\/www.bloomsburycollections.com\/book\/drugs-handbook-20122013\/"}},"issued":{"date-parts":[[2011]]},"references-count":0,"URL":"https:\/\/doi.org\/10.5040\/9781350363595.art-1118","published":{"date-parts":[[2011]]}},{"institution":[{"name":"Chulalongkorn University","acronym":["CU"],"place":["Bangkok, Thailand"],"department":["Environmental Management"]}],"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:15:30Z","timestamp":1767208530892,"version":"build-2238731810"},"reference-count":0,"publisher":"Office of Academic Resources, Chulalongkorn University","content-domain":{"domain":[],"crossmark-restriction":false},"abstract":"<jats:p>A common practice by fish farmers to change the sex of Nile tilapia from female to male is to use a male hormone, methyltestosterone (MT) to induce the sex of the tilapia. MT is an anabolic steroid with a solubility of about 3.4 mg\/L. MT is fed to Tilapia at a rate of 0.06 mg per 1 kg of normal food during the first 30 days after hatching. Due to the properties of MT (high Kow and low water solubility), MT is preferably sorbed onto sediments of the fish pond. Therefore it is possible for MT to contaminate the environment and impact other aquatic organisms. However, there are not many studies on the sorption of MT onto soils and sediment. This research studies the sorption of MT onto five different types of soils and a sediment and the effect of pH and salinity on the sorption of MT using batch sorption experiments. The sorption coefficients (Kd) of MT onto sand, laterite soil, garden soil-1, garden soil-2, garden soil-3 and sediment were 4.6, 1.2, 49.4, 119.1, 122.8, and 168.8 L\/kg, respectively. Sorption of MT onto these five soils were found to be positively correlated with the organic contents. Sorption of MT onto sand and garden soil-1 were not affected by pH and salinity concentration. However, the sorption of MT onto sediment were significantly affected by pH and salinity. The Kd value for the sediment increased from 299.0 to 433.1 L\/kg when the pH decreased from 6.9 to 5.4 and increased from 231.50 to 495.20 L\/kg when the salinity increased from 0.5 to 20 g\/L. For materials with very low organic carbon content (&lt; 0.01%), it is possible that surface area may play a role in sorption of MT as shown by the slightly higher sorption of MT onto sand as compared to laterite soils.<\/jats:p>","DOI":"10.58837\/chula.the.2008.2054","type":"dissertation","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T15:29:01Z","timestamp":1742916541000},"approved":{"date-parts":[[2008]]},"source":"Crossref","is-referenced-by-count":0,"title":["Sorption of methyltestosterone onto sediments and soils"],"prefix":"10.58837","author":[{"sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawittra","family":"Chotisukarn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37481","deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T15:29:01Z","timestamp":1742916541000},"score":18.283144,"degree":["Master of Science"],"resource":{"primary":{"URL":"https:\/\/digiverse.chula.ac.th\/Info\/item\/dc:76266"}},"issued":{"date-parts":[[null]]},"references-count":0,"aliases":["10.58837\/chula.the.2008.2055"],"URL":"https:\/\/doi.org\/10.58837\/chula.the.2008.2054"},{"institution":[{"name":"Chulalongkorn University","acronym":["CU"],"place":["Bangkok, Thailand"],"department":["Pharmaceutical Chemistry"]}],"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:40:04Z","timestamp":1742935204495,"version":"3.40.3"},"reference-count":0,"publisher":"Office of Academic Resources, Chulalongkorn University","content-domain":{"domain":[],"crossmark-restriction":false},"abstract":"<jats:p>Methyltestosterone in pharmaceutical preparations, especially vitamin-hormone preparations, could be determined accurately and rapidly by spectrofluorodensitometer. Methyl - testosterone was separated from other substances by using precoated TLC plate aluminum oxide 150 F254 (type T). A 60:40 mixture of benzene and diethyl ether was selected as mobile phase. The chromatogram was heated at 150\u00b0, \u22bf4-3-keto group of methyltestosterone molecule was converted to blue fluorescent compound, in which aluminum oxide acted as oxidation catalyst. The blue fluorescence intensity of spots were measured using spectrofluorodensitometer with maximum excitation wavelength at 366 nm and maximum emission wavelength at 454 nm. The method of determination of methyltestosterone in commercially available vitamin-hormone preparations in various formulations and dosage forms gave high accuracy and good reproducibility. The proposed method which was convenient and selective, is a useful method for quality control of methyltestosterone in pharmaceutical preparations.<\/jats:p>","DOI":"10.58837\/chula.the.1982.629","type":"dissertation","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:01:43Z","timestamp":1742932903000},"approved":{"date-parts":[[1982]]},"source":"Crossref","is-referenced-by-count":0,"title":["Spectrofluorodensitometric determination of methyltestosterone in vitamin-hormone preparations"],"prefix":"10.58837","author":[{"sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaovalak","family":"Wattanapicis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37481","deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T20:01:44Z","timestamp":1742932904000},"score":17.604092,"degree":["Master of Science in Pharmacy"],"resource":{"primary":{"URL":"https:\/\/digiverse.chula.ac.th\/Info\/item\/dc:77373"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.58837\/chula.the.1982.629"},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T12:55:44Z","timestamp":1649163344345},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1982,1,1]],"date-time":"1982-01-01T00:00:00Z","timestamp":378691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions"],"published-print":{"date-parts":[[1982,1]]},"DOI":"10.1007\/bf03265514","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T21:54:46Z","timestamp":1361397286000},"page":"5-5","source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.1007","volume":"45","member":"297","published-online":{"date-parts":[[2013,2,4]]},"container-title":["Reactions"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03265514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03265514\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03265514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T01:50:35Z","timestamp":1558489835000},"score":17.32275,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03265514"}},"issued":{"date-parts":[[1982,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,1]]}},"alternative-id":["BF03265514"],"URL":"https:\/\/doi.org\/10.1007\/bf03265514","ISSN":["0157-7271"],"issn-type":[{"value":"0157-7271","type":"print"}],"published":{"date-parts":[[1982,1]]}},{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:08:52Z","timestamp":1779347332432,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier","isbn-type":[{"value":"9780128012383","type":"print"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/b978-0-12-801238-3.98044-9","type":"book-chapter","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T21:42:16Z","timestamp":1562622136000},"source":"Crossref","is-referenced-by-count":1,"title":["Methyltestosterone"],"prefix":"10.1016","author":[{"given":"Katherine F.","family":"Roby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2013.10.042","article-title":"A novel selective androgen receptor modulator, NEP28, is efficacious in muscle and brain without serious side effects on prostate","volume":"720","author":"Akita","year":"2013","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0015","series-title":"Brenner and Stevens\u2019 Pharmacology","article-title":"Drugs affecting fertility and reproduction","author":"Brenner","year":"2018"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0035","series-title":"Pharmacotherapeutics for advanced practice nurse prescribers","first-page":"615","article-title":"Drugs affecting the reproductive system","author":"Dewel","year":"2015"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.steroids.2015.11.004","article-title":"Synthesis and chemical reactions of the steroidal hormone 17alpha-methyltestosterone","volume":"105","author":"El-Desoky","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0025","unstructured":"FDA Perscribing Information, n.d. Methyltestosterone FDA perscribing information [Online]. Available: https:\/\/www.drugs.com\/pro\/methyltestosterone.html [Accessed]."},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0030","series-title":"Doping in sports: Biochemical principles, Effects and analysis","article-title":"Synthetic anabolic agents: Steroids and nonsteroidal selective androgen receptor modulators","author":"Mario","year":"2010"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0040","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1210\/en.2011-1164","article-title":"Endocrine characterization of the designer steroid methyl-1-testosterone: Investigations on tissue-specific anabolic-androgenic potency, side effects, and metabolism","volume":"152","author":"Parr","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","article-title":"Anabolic steroid-induced hypogonadism: Diagnosis and treatment","volume":"101","author":"Rahnema","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0050","unstructured":"Gold Standard. 2019. Drug Monograph: Methyltestosterone [Online]. Available: https:\/\/www.drugs.com\/monograph\/methyltestosterone.html [Accessed]."},{"key":"10.1016\/B978-0-12-801238-3.98044-9_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.metabol.2018.03.007","article-title":"Testosterone replacement therapy: For whom, when and how?","volume":"86","author":"Tsametis","year":"2018","journal-title":"Metabolism"}],"container-title":["Reference Module in Biomedical Sciences"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128012383980449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780128012383980449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T21:42:19Z","timestamp":1562622139000},"score":17.321653,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780128012383980449"}},"issued":{"date-parts":[[2019]]},"ISBN":["9780128012383"],"references-count":10,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-801238-3.98044-9","published":{"date-parts":[[2019]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T14:15:37Z","timestamp":1648822537364},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"322","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[1990,10]]},"DOI":"10.2165\/00128415-199003220-00038","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T08:25:50Z","timestamp":1196929550000},"page":"10","source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Reactions Weekly"],"language":"en","deposited":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T17:24:00Z","timestamp":1362158640000},"score":16.993828,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128415-199003220-00038"}},"subtitle":[""],"issued":{"date-parts":[[1990,10]]},"references-count":0,"journal-issue":{"issue":"322"},"URL":"https:\/\/doi.org\/10.2165\/00128415-199003220-00038","ISSN":["0114-9954"],"issn-type":[{"value":"0114-9954","type":"print"}],"published":{"date-parts":[[1990,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:06:44Z","timestamp":1649106404528},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T00:00:00Z","timestamp":1069372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aquatic Toxicology"],"DOI":"10.1016\/j.aquatox.2003.07.005","type":"journal-article","created":{"date-parts":[[2003,11,24]],"date-time":"2003-11-24T14:09:05Z","timestamp":1069682945000},"source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic basis for estrogenic effects in fathead minnow (Pimephales promelas) following exposure to the androgen 17\u03b1-methyltestosterone: conversion of 17\u03b1-methyltestosterone to 17\u03b1-methylestradiol"],"prefix":"10.1016","author":[{"given":"M","family":"Hornung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","published-online":{"date-parts":[[2003,11,21]]},"container-title":["Aquatic Toxicology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166-445X(03)00199-1?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166-445X(03)00199-1?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T20:00:22Z","timestamp":1550347222000},"score":16.986732,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166445X03001991"}},"issued":{"date-parts":[[2003,11,21]]},"references-count":0,"alternative-id":["S0166-445X(03)00199-1"],"URL":"https:\/\/doi.org\/10.1016\/j.aquatox.2003.07.005","ISSN":["0166-445X"],"issn-type":[{"value":"0166-445X","type":"print"}],"published":{"date-parts":[[2003,11,21]]}},{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:52:27Z","timestamp":1757613147814,"version":"3.44.0"},"reference-count":0,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323709576"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-323-70957-6.00352-6","type":"book-chapter","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T07:41:34Z","timestamp":1615534894000},"page":"601-602","source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.1016","author":[{"given":"Mark G.","family":"Papich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Papich Handbook of Veterinary Drugs"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323709576003526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323709576003526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:50:51Z","timestamp":1757008251000},"score":16.8143,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323709576003526"}},"issued":{"date-parts":[[2021]]},"ISBN":["9780323709576"],"references-count":0,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-70957-6.00352-6","published":{"date-parts":[[2021]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:19:02Z","timestamp":1648606742516},"reference-count":0,"publisher":"Springer Science and Business Media LLC","issue":"286","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reactions Weekly"],"published-print":{"date-parts":[[1990,2]]},"DOI":"10.2165\/00128415-199002860-00027","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T08:24:29Z","timestamp":1196929469000},"page":"8","source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.1007","volume":"&NA;","author":[{"family":"&NA;","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","container-title":["Reactions Weekly"],"language":"en","deposited":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T14:15:55Z","timestamp":1362147355000},"score":16.80837,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/00128415-199002860-00027"}},"subtitle":[""],"issued":{"date-parts":[[1990,2]]},"references-count":0,"journal-issue":{"issue":"286"},"URL":"https:\/\/doi.org\/10.2165\/00128415-199002860-00027","ISSN":["0114-9954"],"issn-type":[{"value":"0114-9954","type":"print"}],"published":{"date-parts":[[1990,2]]}},{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:45:38Z","timestamp":1757612738317,"version":"3.44.0"},"reference-count":0,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323244855"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/b978-0-323-24485-5.00386-7","type":"book-chapter","created":{"date-parts":[[2016,9,4]],"date-time":"2016-09-04T06:15:33Z","timestamp":1472969733000},"page":"519-520","source":"Crossref","is-referenced-by-count":0,"title":["Methyltestosterone"],"prefix":"10.1016","author":[{"given":"Mark G.","family":"Papich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["Saunders Handbook of Veterinary Drugs"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323244855003867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323244855003867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T15:44:55Z","timestamp":1757000695000},"score":16.742537,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323244855003867"}},"issued":{"date-parts":[[2016]]},"ISBN":["9780323244855"],"references-count":0,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-24485-5.00386-7","published":{"date-parts":[[2016]]}},{"institution":[{"name":"Chulalongkorn University","acronym":["CU"],"place":["Bangkok, Thailand"],"department":["Environmental Management"]}],"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T04:19:01Z","timestamp":1742962741659,"version":"3.40.3"},"reference-count":0,"publisher":"Office of Academic Resources, Chulalongkorn University","content-domain":{"domain":[],"crossmark-restriction":false},"abstract":"<jats:p>17\u03b1-methyltestosterone (MT) is a male hormone used commonly to produce an all male population in Nile tilapia farming. MT may remain in the masculinization process and be released into the surrounding water and soil bodies causing adverse impact to ecosystems. This study aims to investigate the occurrence of MT in masculinization pond of Nile tilapia fry and its discharged area. MT was extracted from water and sediment samples using SPE and LPE by methanol, respectively. MT concentration was determined using UPLC-MS\/MS. The average percent recoveries of the extraction method when MT was spiked into water samples (10 and 100 ng\/L) were 80 - 84 %. For the sediment samples, the average percent recoveries (1 and 10 \u00b5g\/kg) were 60 \u2013 71 %. The monitoring during 1-day period was performed to define the time of the day that MT reached the maximum concentration. The maximum MT concentrations in most compartments (water, suspended solid, and settled solid phases) occurred at the end of the last feeding time (16.00). MT was input into the pond through the feed and was released into the environments by two approaches: 1) with the daily overflow water (water phase and suspended solids phase) and 2) with the water (water phase and suspended solid phase) and settled solid that remained in the pond on the last day of operation (day 30). In the overflow water, the overall concentrations of MT (water phase and suspended solid phase) were 0.3 \u2013 39.5 ng\/L. For MT remaining in the pond on day 30, the overall MT concentration was calculated by assuming that MT in all compartments (water, suspended solid, and settled solid phases) distributed homogeneously in the pond as at the end MT in all compartments were released with the pond water. The level of MT was found to be 0.595 ng\/L. Although the ranges of the MT concentrations found in the overflow water were in the ranges reported to affect organisms (6.5 ng\/L), these levels of MT can be reduced due to effect of dilution when the overflow water was released into natural receiving water. Comparing to the total mass of MT supplied into the pond with the feed (148.85 mg), 0.33 % (492.85 \u00b5g) of MT was released with the overflow water along 30 days of operation. MT remaining in the pond on day 30 can be accounted as 0.0009 % (1.33 \u00b5g) of the total MT supplied to the pond. In overall, 0.333% (494.18 \u00b5g) of MT supplied to the pond was released into the environment. In the overflow water, the total mass of MT was 492.85 \u00b5g which can be accounted for 99.73 % of overall of MT released into the environment. Comparing to the overall MT released, MT in the water phase was 96.89 % and was 2.84 % in the suspended solid phase. MT remaining in the pond was 0.27 % of the overall MT released. Combining all MT released, MT distributed 97.06 %, 2.93 %, and &lt;0.005 % in water phase, suspended solid phase, and settled solid phases, respectively. The priority should be given to the overflow water to reduce the risk of MT released into the environment. To investigate the occurrence of MT in the discharged area, the highest concentrations of MT were found at the inlet of the concrete ditch (0.29 ng\/L for water and 0.1 \u00b5g\/kg for settled solids) and the concentrations reduced to 0.21-0.22 ng\/L and 0.06-0.07 \u00b5g\/kg for water phase plus suspended solid phase and settled solid, respectively, at the outlet point of the concrete ditch. The MT concentrations in the receiving water were in the range of 0.13-0.14 ng\/L and it was 0.01 \u00b5g\/kg in the receiving sediment. The levels of MT in the receiving water were found to be lower than the levels reported to affect organisms (6.5 ng\/L). The further study should be done to clarify fate of MT and to develop the method to detect androgenic activity under low levels in the masculinization process of Nile tilapia fry.<\/jats:p>","DOI":"10.58837\/chula.the.2011.2246","type":"dissertation","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:24:29Z","timestamp":1742930669000},"approved":{"date-parts":[[2011]]},"source":"Crossref","is-referenced-by-count":0,"title":["Occurrence of 17 alpha-methyltestosterone in masculinization pond of nile tilapia fry"],"prefix":"10.58837","author":[{"sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanyaratt","family":"Waiyaput","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"37481","deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T19:24:30Z","timestamp":1742930670000},"score":16.65065,"degree":["Master of Science"],"resource":{"primary":{"URL":"https:\/\/digiverse.chula.ac.th\/Info\/item\/dc:76085"}},"issued":{"date-parts":[[null]]},"references-count":0,"URL":"https:\/\/doi.org\/10.58837\/chula.the.2011.2246"}],"items-per-page":20,"query":{"start-index":0,"search-terms":"methyltestosterone zinc"}}}